YU39960B - Process for obtaining (4-piperidinyl)-n-phenyl-amides and carbamates - Google Patents

Process for obtaining (4-piperidinyl)-n-phenyl-amides and carbamates

Info

Publication number
YU39960B
YU39960B YU652/76A YU65276A YU39960B YU 39960 B YU39960 B YU 39960B YU 652/76 A YU652/76 A YU 652/76A YU 65276 A YU65276 A YU 65276A YU 39960 B YU39960 B YU 39960B
Authority
YU
Yugoslavia
Prior art keywords
carbamates
piperidinyl
amides
phenyl
obtaining
Prior art date
Application number
YU652/76A
Other languages
English (en)
Other versions
YU65276A (en
Inventor
Janssen Pharmacetica
Pharmacetica Janssen
Original Assignee
Pharmacetica Janssen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacetica Janssen filed Critical Pharmacetica Janssen
Publication of YU65276A publication Critical patent/YU65276A/xx
Publication of YU39960B publication Critical patent/YU39960B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU652/76A 1975-03-14 1976-03-12 Process for obtaining (4-piperidinyl)-n-phenyl-amides and carbamates YU39960B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55851175A 1975-03-14 1975-03-14
US05/648,685 US3998834A (en) 1975-03-14 1976-01-13 N-(4-piperidinyl)-n-phenylamides and -carbamates

Publications (2)

Publication Number Publication Date
YU65276A YU65276A (en) 1982-08-31
YU39960B true YU39960B (en) 1985-06-30

Family

ID=27071767

Family Applications (1)

Application Number Title Priority Date Filing Date
YU652/76A YU39960B (en) 1975-03-14 1976-03-12 Process for obtaining (4-piperidinyl)-n-phenyl-amides and carbamates

Country Status (28)

Country Link
US (1) US3998834A (de)
JP (1) JPS5946217B2 (de)
AT (1) AT359493B (de)
AU (1) AU503632B2 (de)
BG (1) BG28259A3 (de)
CA (1) CA1080232A (de)
CH (1) CH629486A5 (de)
CZ (1) CZ278060B6 (de)
DE (1) DE2610228A1 (de)
DK (1) DK148960C (de)
ES (1) ES446034A1 (de)
FI (1) FI61481C (de)
FR (1) FR2303546A1 (de)
GB (1) GB1538938A (de)
HU (1) HU172963B (de)
IE (1) IE42512B1 (de)
IL (1) IL49204A (de)
IT (1) IT1057988B (de)
LU (1) LU74511A1 (de)
NL (1) NL185279C (de)
NO (1) NO146162C (de)
NZ (1) NZ180096A (de)
PH (1) PH12746A (de)
PL (1) PL102474B1 (de)
PT (1) PT64898B (de)
SE (1) SE426486B (de)
SU (1) SU1227109A3 (de)
YU (1) YU39960B (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179569A (en) * 1975-03-14 1979-12-18 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-N-phenylamides
US4208418A (en) * 1975-09-23 1980-06-17 Janssen Pharmaceutica N.V. N-Aryl-N-(1-alkyl-4-piperidinyl)arylacetamides
US4225606A (en) * 1975-09-23 1980-09-30 Janssen Pharmaceutica N.V. N-Aryl-N-(1-L-4-piperidinyl)arylacetamides
FR2389622B1 (de) * 1977-05-05 1982-05-21 Janssen Pharmaceutica Nv
US4167574A (en) * 1978-03-13 1979-09-11 Janssen Pharmaceutica, N.V. N-phenyl-N-(4-piperidinyl)amides
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
FR2608602A1 (fr) * 1986-12-23 1988-06-24 Cerm Cent Europ Rech Mauvernay Nouvelles 3-piperidineamines ou 3-azepineamines substituees, leur preparation et leurs applications en therapeutique
US4849521A (en) * 1987-11-02 1989-07-18 Boc, Inc. Stereoselective preparation of 3-substituted-4-piperidine compounds and derivatives
US4957929A (en) * 1987-11-02 1990-09-18 Boc, Inc. 4-phenyl-4-[N-(phenyl)amido]piperidine compounds and pharmaceutical compositions employing such compounds
US5013742A (en) * 1987-11-02 1991-05-07 Boc, Inc. 4-phenyl-4-N-(phenyl) amido piperidine derivatives and pharmaceutical compositions and method employing such compounds
US4921864A (en) * 1987-11-02 1990-05-01 Boc, Inc. 4-Phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
USRE33495E (en) * 1987-11-02 1990-12-18 Boc, Inc. Stereoselective preparation of 3-substituted-4-anilino-piperidine compounds and derivatives
US4791121A (en) * 1987-11-02 1988-12-13 The Boc Group, Inc. 4-phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
US4791120A (en) * 1987-12-31 1988-12-13 The Boc Group, Inc. 4-heteropentacyclic-4-[N-(phenyl)amino] piperidine derivatives and pharmaceutical compositions and method employing such compounds
US4801615A (en) * 1987-12-31 1989-01-31 The Boc Group, Inc. 4-heterohexacyclic-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
US5019583A (en) * 1989-02-15 1991-05-28 Glaxo Inc. N-phenyl-N-(4-piperidinyl)amides useful as analgesics
US5145967A (en) * 1989-04-20 1992-09-08 Anaquest, Inc. Method for preparing 4-alkoxyalkyl-4-phenylaminopiperdines and derivatives thereof
USRE34201E (en) * 1989-04-20 1993-03-23 Anaquest, Inc. N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
US5053411A (en) * 1989-04-20 1991-10-01 Anaquest, Inc. N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
US4939161A (en) * 1989-05-12 1990-07-03 Boc, Inc. Analgesic N-aryl-N-[1-substituted-3,5-dimethyl-4-piperidinyl]amides
US4994471A (en) * 1989-05-12 1991-02-19 Boc, Inc. N-aryl-N-(1-substituted-3-alkoxy-4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds
US5100903A (en) * 1989-05-12 1992-03-31 Anaquest, Inc. N-aryl-n-(1-substituted-3-alkoxy-4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds
US5039804A (en) * 1989-12-13 1991-08-13 Glaxo Inc. Preparation of substituted alkali metal piperidine-4-carboxylates
US5126455A (en) * 1989-12-13 1992-06-30 Glaxo Inc. Preparation of substituted alkali metal piperidine-4-carboxylates
US5214148A (en) * 1990-12-18 1993-05-25 Glaxo Inc. Analgesic N-phenyl-N-(3-OR1 -3-ME-4-piperidinyl)amides
US5130321A (en) * 1990-12-18 1992-07-14 Glaxo Inc. Analgesic n-phenyl-n-(3-or 1-3-me-4-piperidinyl)amides
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
GB9316863D0 (en) * 1993-08-13 1993-09-29 Glaxo Group Ltd Chemical process
US5489689A (en) * 1993-09-30 1996-02-06 Mallinckrodt Chemical, Inc. Preparation of piperidine derivatives
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
EP1182192A4 (de) * 1999-04-09 2002-06-05 Mochida Pharm Co Ltd 4-hydroxypiperidin-derivate mit antiarrhythmischem effekt
US7361666B2 (en) * 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
JP2003515588A (ja) * 1999-12-06 2003-05-07 マリンクロッド・インコーポレイテッド アルフェンタニル、スフェンタニルおよびレミフェンタニルの新合成法
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
EP1795526A4 (de) * 2004-09-14 2010-10-13 Nippon Chemiphar Co N-substituierte n-(4-piperidinyl)amidderivate
JP2008088057A (ja) * 2005-03-23 2008-04-17 Nippon Chemiphar Co Ltd Ｎ−置換−ｎ−（４−ピペリジニル）アミド誘導体
EP1966140A1 (de) * 2005-11-17 2008-09-10 Mallinckrodt, Inc. Verfahren zur synthese von remifentanil
CN101374812A (zh) * 2006-01-24 2009-02-25 马林克罗特公司 合成瑞芬太尼的方法
EP1867635A1 (de) * 2006-06-15 2007-12-19 Kern Pharma, S.L. Verfahren zur Herstellung von Remifentanil, seine Zwischenprodukte, die Verwendung von diesen Zwischenprodukten und das Verfahren zur deren Herstellung
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
WO2008005423A1 (en) * 2006-07-03 2008-01-10 Cambrex Charles City, Inc. Improved method of making sufentanil
US20100048908A1 (en) * 2006-11-29 2010-02-25 Brian Kai-Ming Cheng Process for Remifentanil Synthesis
US20100056574A1 (en) * 2008-09-04 2010-03-04 Mallinckrodt Inc. Crystalline Forms of Sufentanil
WO2010053944A1 (en) * 2008-11-04 2010-05-14 Cambrex Charles City, Inc. Improved method of making piperidine derivatives
WO2012037309A2 (en) 2010-09-17 2012-03-22 Mallinckrodt Llc Improved process for the preparation of sufentanil base and related compounds
EP2455377B1 (de) 2010-11-11 2014-07-09 hameln rds gmbh Synthese von Fentanyl Analoga
US20120310140A1 (en) 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
SG10201913593WA (en) * 2013-03-13 2020-02-27 Harvard College Stapled and stitched polypeptides and uses thereof
EP3233077A4 (de) 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamin-d2-rezeptor-liganden
EP3233799B1 (de) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamin-d2-rezeptor-liganden
BR112017025115B1 (pt) 2015-05-27 2023-03-14 Mallinckrodt Llc Processo para formar citrato de sufentanila a partir de base de sufentanila
CN106854203B (zh) * 2015-12-08 2020-12-01 江苏恩华药业股份有限公司 枸橼酸舒芬太尼的新晶型及其制备方法
ES2699636T3 (es) 2016-01-29 2019-02-12 Bioka S R O Nuevo procedimiento para la preparación de derivados de N-fenil-N-(4-piperidinil) amida, como remifentanilo y carfentanilo
CN108503579B (zh) * 2018-03-28 2021-03-26 南京医科大学 芬太尼类似物及其应用
CN113214139B (zh) * 2020-02-03 2022-03-04 江苏谛奇医药科技有限公司 哌啶酰胺类衍生物及其制备方法、其药物组合物、其单晶培养方法及其应用
CA3185469A1 (en) 2020-08-14 2022-02-17 Novartis Ag Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
CN114262320A (zh) * 2021-12-28 2022-04-01 宜昌人福药业有限责任公司 一种利用连续流微通道反应器制备苯胺基哌啶类药物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE623427A (de) * 1961-10-10
US3171838A (en) * 1961-10-10 1965-03-02 Res Lab Dr C Janssen N V Aroylalkyl and hydroxyaralkyl derivatives of 4-(n-arylalkanamido)-piperidines and related compounds

Also Published As

Publication number Publication date
FI760646A (de) 1976-09-15
IE42512B1 (en) 1980-08-27
AT359493B (de) 1980-11-10
NL7602612A (nl) 1976-09-16
CH629486A5 (de) 1982-04-30
ES446034A1 (es) 1977-10-16
NZ180096A (en) 1978-06-02
GB1538938A (en) 1979-01-24
NL185279C (nl) 1990-03-01
FR2303546B1 (de) 1980-11-28
FR2303546A1 (fr) 1976-10-08
PH12746A (en) 1979-08-09
DK148960B (da) 1985-12-02
LU74511A1 (de) 1976-09-01
IT1057988B (it) 1982-03-30
DK110376A (da) 1976-09-15
ATA184676A (de) 1980-04-15
YU65276A (en) 1982-08-31
NO760591L (de) 1976-09-15
CZ278060B6 (en) 1993-08-11
AU1200676A (en) 1977-09-22
NO146162B (no) 1982-05-03
DK148960C (da) 1986-06-23
SE7602740L (sv) 1976-09-15
CA1080232A (en) 1980-06-24
HU172963B (hu) 1979-01-28
NL185279B (nl) 1989-10-02
US3998834A (en) 1976-12-21
FI61481C (fi) 1982-08-10
DE2610228C2 (de) 1990-04-05
JPS51115478A (en) 1976-10-12
CZ163276A3 (en) 1993-03-17
FI61481B (fi) 1982-04-30
SU1227109A3 (ru) 1986-04-23
IE42512L (en) 1976-09-14
SE426486B (sv) 1983-01-24
PT64898A (en) 1976-04-01
NO146162C (no) 1982-08-11
IL49204A (en) 1979-11-30
JPS5946217B2 (ja) 1984-11-10
IL49204A0 (en) 1976-05-31
AU503632B2 (en) 1979-09-13
BG28259A3 (en) 1980-03-25
PT64898B (en) 1977-08-18
DE2610228A1 (de) 1976-09-30
PL102474B1 (pl) 1979-03-31

Similar Documents

Publication Publication Date Title
YU39960B (en) Process for obtaining (4-piperidinyl)-n-phenyl-amides and carbamates
ES462287A1 (es) Procedimiento para resolver acidos ciclopropangoicarboxili- cos sustituidos racemicos.
BG33006A3 (en) Method for obtaining of n- (perfluoracil)- n- phosphonomethyl- glycine compounds
HU172633B (hu) Sposob poluchenija slozhnykh efirov tiazolinil- ili 5,6-digidro-4h-1,3-tiazinil-benzimidazola s aktivnost'ju protiv virusov
PT68542A (en) Process for preparing 3- 2-hydroxy-4-(substituted) phenyl-ts and intermediates therefor. azacycloalkanes and derivatives thereof as analgesic agen
ES475558A1 (es) Procedimiento para la preparacion de derivados de tiazolidi-na.
ES441404A1 (es) Un procedimiento de preparacion de acido 5-fluor-2-metil-1- (p-metilsulfinil-benciliden) indenil-3-acetico.
JPS5265078A (en) Process for producing fermentation base of compost
HU173366B (hu) Sposob dlja mikrobiologicheskojj oksidacii steroidov
JPS52264A (en) Process for preparing novel isoxazole derivatives
ES452736A1 (es) Un procedimiento para preparar compuestos de aroil-fenildi- deno y aroil-fenilnaftaleno.
CS191322B2 (en) Process for preparing new disubstituted phenolethers of 3-amino-2-hydroxypropane
RO70076A (ro) Procedeu pentru prepararea unor 4,4-diaril-2-hidroxibutilamine
EG12648A (en) Process for the production of 9-hydroxydibenzo(b,cl)pyrans and intermediates thereof
CA492022A (en) Process of producing n-alkylated derivatives of aromatic amines
YU130682A (en) Process for obtaining n-(benzene-sulfonyl)-carbamate
JPS51143652A (en) Process for preparing 3-halogeno-4- homoisotwistanes
RO69421A (ro) Procedeu pentru prepararea unor oxazolidine n-substituite
RO68637A (ro) Procedeu pentru prepararea unor 3,5-difenil-4(1h)-piridone
CS184833B2 (en) Method of producing therapeutically active n-methyl-n-cyclohexyl-/2-amino-3,5-dibrombenzyl/amine
EG12539A (en) Process for preparing of novel n-(piperidinyl)alkyl,arylcarboxamine derivatives
AU3228157A (en) Process for producing n-(2, 2, 2-trinitroethyl) amides
HU173709B (hu) Sposob poluchenija intermediarnykh soedinenill dlja prostaglandinov
ES388005A1 (es) Procedimiento de obtencion del ester bis-(metilcarbamico) del 2,6-piridindimetanol.